Hepatitis Monthly

Published by: Kowsar

Immune Responses to Single-Dose Versus Double-Dose Hepatitis B Vaccines in Healthcare Workers not Responding to the Primary Vaccine Series: A Randomized Clinical Trial

Farahnaz Joukar 1 , Fariborz Mansour-Ghanaei 1 , * , Mohammad-Reza Naghipour 1 and Mehrnaz Asgharnezhad 1
Authors Information
1 Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences, Rasht, IR Iran
Article information
  • Hepatitis Monthly: February 01, 2016, 16 (2); e32799
  • Published Online: February 27, 2016
  • Article Type: Research Article
  • Received: August 30, 2015
  • Revised: January 25, 2016
  • Accepted: January 27, 2016
  • DOI: 10.5812/hepatmon.32799

To Cite: Joukar F, Mansour-Ghanaei F, Naghipour M, Asgharnezhad M. Immune Responses to Single-Dose Versus Double-Dose Hepatitis B Vaccines in Healthcare Workers not Responding to the Primary Vaccine Series: A Randomized Clinical Trial, Hepat Mon. 2016 ; 16(2):e32799. doi: 10.5812/hepatmon.32799.

Abstract
Copyright © 2016, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Ghany MG, Perrillo R, Li R, Belle SH, Janssen HL, Terrault NA, et al. Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype. Clin Gastroenterol Hepatol. 2015; 13(1): 183-92[DOI][PubMed]
  • 2. Lavanchy D. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol. 2005; 34 Suppl 1-3[PubMed]
  • 3. MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med. 2015; 5(5)[DOI][PubMed]
  • 4. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386(10003): 1546-55[DOI][PubMed]
  • 5.
  • 6. Hepatitis B. Fact sheet.
  • 7. Beekmann SE, Henderson DK. Occupational Exposures among Healthcare Workers: New Methods for Prevention and Recommended Postexposure Prophylaxis for HIV and Hepatitis B and C. Curr Treat Options Infect Dis. 2015; 7(1): 28-38[DOI]
  • 8. Mueller A, Stoetter L, Kalluvya S, Stich A, Majinge C, Weissbrich B, et al. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania. BMC Infect Dis. 2015; 15: 386[DOI][PubMed]
  • 9. Abeje G, Azage M. Hepatitis B vaccine knowledge and vaccination status among health care workers of Bahir Dar City Administration, Northwest Ethiopia: a cross sectional study. BMC Infect Dis. 2015; 15: 30[DOI][PubMed]
  • 10. Panlilio AL, Orelien JG, Srivastava PU, Jagger J, Cohn RD, Cardo DM. Estimate of the annual number of percutaneous injuries among hospital-based healthcare workers in the United States, 1997-1998. Infect Control Hosp Epidemiol. 2004; 25(7): 556-62[DOI][PubMed]
  • 11. Lewis JD, Enfield KB, Sifri CD. Hepatitis B in healthcare workers: Transmission events and guidance for management. World J Hepatol. 2015; 7(3): 488-97[DOI][PubMed]
  • 12. Shefer AM, Healthcare Infection Control Practices Advisory Committee . Immunization of health-care personnel: recommendations of the Advisory Committee on Immunization Practices (ACIP). 2011;
  • 13. Halperin SA, McNeil S, Langley JM, Smith B, MacKinnon-Cameron D, McCall-Sani R, et al. Safety and immunogenicity of different two-dose regimens of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in healthy young adults. Vaccine. 2012; 30(36): 5445-8[DOI][PubMed]
  • 14. Romano L, Paladini S, Van Damme P, Zanetti AR. The worldwide impact of vaccination on the control and protection of viral hepatitis B. Dig Liver Dis. 2011; 43 Suppl 1-7[DOI][PubMed]
  • 15. Floreani A, Baldo V, Cristofoletti M, Renzulli G, Valeri A, Zanetti C, et al. Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine. 2004; 22(5-6): 607-10[PubMed]
  • 16. Wiersma ST. Hepatitis B vaccine continues to provide long-term protection to healthcare workers. J Hepatol. 2009; 51(4): 826[DOI][PubMed]
  • 17. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005; 54: 1-31[PubMed]
  • 18. Chathuranga LS, Noordeen F, Abeykoon AM. Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka. Int J Infect Dis. 2013; 17(11)-9[DOI][PubMed]
  • 19. Perera J, Perera B, Gamage S. Seroconversion after hepatitis B vaccination in healthy young adults, and the effect of a booster dose. Ceylon Med J. 2002; 47(1): 6-8[PubMed]
  • 20. Praharaj I, John SM, Bandyopadhyay R, Kang G. Probiotics, antibiotics and the immune responses to vaccines. Philos Trans R Soc Lond B Biol Sci. 2015; 370(1671)[DOI][PubMed]
  • 21. Zuckerman JN. Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines. J Med Virol. 2006; 78(2): 169-77[DOI][PubMed]
  • 22. Jha R, Lakhtakia S, Jaleel MA, Narayan G, Hemlatha K. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders. Ren Fail. 2001; 23(5): 629-36[PubMed]
  • 23. Chou HY, Lin XZ, Pan WY, Wu PY, Chang CM, Lin TY, et al. Hydrogel-delivered GM-CSF overcomes nonresponsiveness to hepatitis B vaccine through the recruitment and activation of dendritic cells. J Immunol. 2010; 185(9): 5468-75[DOI][PubMed]
  • 24. Hasan MS, Agosti JM, Reynolds KK, Tanzman E, Treanor JJ, Evans TG. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults. J Infect Dis. 1999; 180(6): 2023-6[DOI][PubMed]
  • 25. Schirmer A, Alter K, Kotz SA, Friederici AD. Lateralization of prosody during language production: a lesion study. Brain Lang. 2001; 76(1): 1-17[DOI][PubMed]
  • 26. Rendi-Wagner P, Shouval D, Genton B, Lurie Y, Rumke H, Boland G, et al. Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine. Vaccine. 2006; 24(15): 2781-9[DOI][PubMed]
  • 27. Zuckerman JN, Sabin C, Craig FM, Williams A, Zuckerman AJ. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study. BMJ. 1997; 314(7077): 329-33[PubMed]
  • 28. Bookstaver PB, Foster JL, Lu ZK, Mann JR, Ambrose C, Grant A, et al. Hepatitis B virus seroconversion rates among health sciences students in the southeastern United States. J Am College Health. 2016; 64(1): 69-73
  • 29. Cardell K, Akerlind B, Sallberg M, Fryden A. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. J Infect Dis. 2008; 198(3): 299-304[DOI][PubMed]
  • 30. David MC, Ha SH, Paynter S, Lau C. A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination. Vaccine. 2015; 33(48): 6564-9[DOI][PubMed]
  • 31. Bahmani MK, Khosravi A, Mobasser A, Ghezelsofla E. Seroprevalence of hepatitis B virus infection and vaccination compliance among health care workers in Fars Province, Iran. Arch Clin Infect Dis. 2010; 5(1): 45-50
  • 32. Fisman DN, Agrawal D, Leder K. The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis. 2002; 35(11): 1368-75[DOI][PubMed]
  • 33. Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA. 1993; 270(24): 2935-9[PubMed]
  • 34. Bender TJ, Sharapov U, Utah O, Xing J, Hu D, Rybczynska J, et al. Hepatitis B vaccine immunogenicity among adults vaccinated during an outbreak response in an assisted living facility--Virginia, 2010. Vaccine. 2014; 32(7): 852-6[DOI][PubMed]
  • 35. Poland GA, Jacobson RM. Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med. 2004; 351(27): 2832-8[DOI][PubMed]
  • 36. Poland GA. Hepatitis B immunization in health care workers. Dealing with vaccine nonresponse. Am J Prev Med. 1998; 15(1): 73-7[PubMed]
  • 37. Sjogren MH. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination. Am J Med. 2005; 118 Suppl 10A: 34S-9S[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments